CureVac N.V. (CVAC)

NASDAQ: CVAC · IEX Real-Time Price · USD
13.48
+0.09 (0.67%)
At close: Aug 12, 2022 4:00 PM
13.85
+0.37 (2.74%)
After-hours: Aug 12, 2022 7:36 PM EDT

Income Statement (Annual)

Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Year 2021202020192018
Revenue
102.9948.8717.4212.87
Revenue Growth (YoY)
110.74%180.61%35.31%-
Cost of Revenue
238.214.1727.9817.74
Gross Profit
-135.2134.7-10.57-4.87
Selling, General & Admin
102.1554.2950.7226.37
Research & Development
815.91113.8143.2441.72
Other Operating Expenses
-640.99-23.58-5.04-0.15
Operating Expenses
277.06144.5188.9367.95
Operating Income
-412.26-109.82-99.5-72.82
Interest Expense / Income
10.3422.11.460.28
Other Expense / Income
-10.1-2.07-0.83-1.97
Pretax Income
-412.5-129.85-100.13-71.13
Income Tax
-0.78-0.73-0.250.11
Net Income
-411.72-129.12-99.87-71.24
Net Income Common
-411.72-129.12-99.87-71.24
Shares Outstanding (Basic)
187176176-
Shares Change
6.00%---
EPS (Basic)
-2.21-0.98-1.03-0.74
EPS (Diluted)
-2.21-0.98-1.03-0.74
Free Cash Flow Per Share
-4.582.75-0.56-
Gross Margin
-131.30%71.00%-60.70%-37.90%
Operating Margin
-400.30%-224.70%-571.30%-565.80%
Profit Margin
-399.80%-264.20%-573.50%-553.50%
Free Cash Flow Margin
-832.50%994.60%-563.50%-648.90%
Effective Tax Rate
0.19%0.56%0.25%-0.15%
EBITDA
-386.49-97.07-91.5-67.08
EBITDA Margin
-375.30%-198.60%-525.40%-521.10%
Depreciation & Amortization
15.6710.677.163.78
EBIT
-402.16-107.75-98.67-70.86
EBIT Margin
-390.50%-220.50%-566.50%-550.50%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).